We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Perspectum has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its precision oncology decision support tool, dubbed Hepatica, for liver cancer. According to the
Medical device company Ancora Heart has recruited the first patient in the CORCINCH-HF pivotal trial of the AccuCinch ventricular restoration system. The trial has been designed to assess
Japanese company Olympus has agreed to acquire Netherlands-based multispectral imaging solutions provider Quest Photonic Devices for up to €50m. The deal also includes milestone payments to strengthen the
Singapore-based Osteopore International has teamed up with Netherlands-based Maastricht University Medical Centre (UMC+) for the development of a bioresorbable bone implant solution to prevent leg amputations. Claimed to
SetPoint Medical has secured $64m in preferred stock financing to support the pivotal trial of its novel bioelectronic platform. With an initial focus on rheumatoid arthritis (RA) disease,
Health technology company Royal Philips has introduced a new software application called Abdominal Aortic Aneurysm (AAA) Model to offer physicians an advanced solution to manage AAA patients. Philips
Swiss drugmaker Novartis has announced an investment in novel drug delivery systems developer Credence MedSystems. Novartis’ investment is aimed at improving the safety and user experience of its
Spine technology company Spinal Elements has secured approval from the US Food and Drug Administration (FDA) for its Lucent XP-Curved expandable interbody device. Lucent XP-Curved is said to
Healthcare technology company Mindray has expanded its VS Series product portfolio with the introduction of new VS 9 and VS 8 vital signs monitors. Available in Europe, Australia
Abbott has secured CE mark approval for two new indications of its Panbio Covid-19 Ag rapid test device to detect the SARS-CoV-2 virus. The Panbio Covid-19 Ag rapid